The feds have ordered 300 million doses of a potential coronavirus vaccine from British drugmaker AstraZeneca, officials said Thursday.

The company will get up to $1.2 billion from the US Department of Health and Human Services to speed the development and production of the vaccine with the goal of delivering the first doses as early as October, according to officials.

The deal between AstraZeneca and HHS’s Biomedical Advanced Research and Development Authority includes clinical studies that will start this summer with about 30,000 US volunteers, officials said.